Stanford RH, Gilsenan AW, Lincourt W, Lankevich C, Ortega H. Status of asthma control in primary care in the US: results from the asthma control characteristics and prevalence survey study (ACCESS). Presented at the American College of Asthma Allergy and Immunology Annual Meeting; November 2008.
Lincourt W, Stanford RH, Gilsenan AW, Lankevich C, Vanderpuije A, Ortega H. Status of asthma control in pediatric practices in the US: results from the asthma control characteristics and prevalence survey study (ACCESS). Poster presented at the American College of Nurse Practitioner Meeting; October 2008.
Gilsenan AW, Ladner A, Varas-Lorenzo C, Kold Olesen T, Karup C, Andrews EB. Incidence of cardiovascular and cerebrovascular events among men with prostate cancer. Poster presented at the 24th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 9, 2008. Copenhagen, Denmark.
Andrews EB, Irish WD, Gilsenan AW, Campbell WH. Evaluation of therapeutic risk management programs. In: Hartzema AG, Tilson HH, Arnold Chan K, editors. Pharmacoepidemiology and therapeutic risk management. 1st ed. Cincinnati: United States. Harvey Whitney Books; 2008. p.637-52.
Andrews EB, Gilsenan AW, Cook SF. Therapeutic risk management interventions: feasibility and effectiveness. In: Pharmacoepidemiology and therapeutic risk management. Cincinnati: United States. Harvey Whitney Books; 2008. p.613-33.
Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001 Dec 19;286(23):2947-55.
Gilsenan AW. Development of a minimum dataset (MDS)-based comorbidity index for a nursing home population. Poster presented at the Fourth International Society for Pharmacoeconomics and Outcomes Research Congress; 2001. [abstract] Value Health. 2001 Sep; 4(6):417-8.